Anteris

AVR.AX

Tags: AU Healthcare Medical - Devices

Anteris Technologies Ltd Price (AVR.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

15,605,878

(12.9423)%

Market Cap of Anteris (AVR.AX)

Market cap:

As of , AVR.AX has a market cap of . This makes AVR.AX the 388th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $7.65-23.93
Market Cap 407.01M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Devices

ceo: Mr. Wayne Geoffrey Paterson
IPO Date: March, 22, 2004
Country: AU
Currency: AUD
Headquaters: Toowong, QLD
Employees: 136

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: